The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.

  1. First select the CSR Section, then a Table/Figure from that section.
  2. Use the Submit button to view the table or figure. You will have options to download a printer-friendly version (PDF) or the data table (CSV) as well.

To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR (PDF, 533 KB) and Technical Notes (PDF, 752 KB) pages.



Download and Print: Download Printer-friendly PDF Download data


Table 1.27

Age-Adjusted U.S. Death Rates and Trends for the Top 15 Cancer Sitesa
Both Sexes by Race/Ethnicity
Race/Ethnicity Primary Site Age-Adjusted Rateb,
2007-2011
Trend (APC)c,
2002-2011
All Races All Sites 173.8 -1.5*
Lung and Bronchus 48.4 -1.9*
Colon and Rectum 15.9 -2.9*
Breast 12.4 -2.1*
Pancreas 10.9 0.4*
Prostatef 8.8 -2.6*
Leukemia 7.0 -0.9*
Non-Hodgkin Lymphoma 6.3 -2.6*
Liver & IBDg 5.8 2.5*
Urinary Bladder 4.4 0.1
Ovaryf 4.4 -2.2*
Brain and ONSg 4.3 -0.4
Esophagus 4.2 -0.7*
Kidney and Renal Pelvis 4.0 -0.9*
Stomach 3.5 -2.9*
Myeloma 3.4 -1.5*
White All Sites 173.3 -1.4*
Lung and Bronchus 49.1 -1.8*
Colon and Rectum 15.5 -2.9*
Breast 12.1 -2.2*
Pancreas 10.8 0.5*
Prostatef 8.1 -2.5*
Leukemia 7.3 -0.8*
Non-Hodgkin Lymphoma 6.6 -2.6*
Liver & IBDg 5.3 2.6*
Brain and ONSg 4.6 -0.2
Urinary Bladder 4.6 0.3*
Ovaryf 4.5 -2.2*
Esophagus 4.3 -0.1
Kidney and Renal Pelvis 4.0 -0.8*
Melanoma of the Skin 3.1 0.6*
Myeloma 3.1 -1.5*
Black All Sites 206.4 -2.1*
Lung and Bronchus 52.0 -2.6*
Colon and Rectum 22.1 -2.8*
Breast 18.0 -1.6*
Prostatef 17.4 -3.3*
Pancreas 13.6 -0.3
Liver & IBDg 7.6 2.5*
Stomach 6.5 -3.3*
Myeloma 6.3 -1.6*
Leukemia 6.0 -1.5*
Corpus and Uterus, NOSf 4.5 0.8
Non-Hodgkin Lymphoma 4.5 -2.0*
Esophagus 4.2 -4.6*
Ovaryf 3.9 -1.9*
Kidney and Renal Pelvis 3.9 -1.0*
Urinary Bladder 3.6 -0.9
Asian/
Pacific Islander
All Sites 107.8 -1.1*
Lung and Bronchus 25.2 -1.1*
Colon and Rectum 11.0 -1.6*
Liver & IBDg 9.8 -1.2*
Pancreas 7.7 0.5
Breast 6.4 -1.5*
Stomach 6.3 -3.7*
Non-Hodgkin Lymphoma 4.1 -1.9*
Prostatef 4.0 -2.6*
Leukemia 4.0 0.8
Ovaryf 2.6 -1.0
Kidney and Renal Pelvis 2.0 2.2
Oral Cavity and Pharynx 1.9 -2.1*
Brain and ONSg 1.9 -0.5
Myeloma 1.8 0.6
Esophagus 1.7 -1.3
American Indian/
Alaska Natived
All Sites 158.0 -1.0*
Lung and Bronchus 39.9 -1.0
Colon and Rectum 17.2 -0.6
Liver & IBDg 9.5 2.0
Pancreas 8.8 1.0
Breast 8.6 -3.0*
Prostatef 8.4 -0.9
Kidney and Renal Pelvis 6.7 -0.5
Stomach 5.2 -5.5*
Leukemia 4.7 -1.3
Non-Hodgkin Lymphoma 4.6 -1.4
Ovaryf 3.9 -0.3
Esophagus 3.3 -3.1*
Myeloma 2.7 -5.6*
Brain and ONSg 2.6 2.1
Urinary Bladder 2.5 3.4
Hispanice All Sites 120.3 -1.3*
Lung and Bronchus 20.9 -2.3*
Colon and Rectum 12.4 -1.7*
Liver & IBDg 8.7 1.5*
Pancreas 8.6 0.3
Breast 8.1 -1.6*
Prostatef 7.3 -2.4*
Stomach 5.6 -2.9*
Non-Hodgkin Lymphoma 5.3 -1.4*
Leukemia 4.8 -0.8*
Kidney and Renal Pelvis 3.6 -1.0
Ovaryf 3.2 -1.7*
Myeloma 2.8 -1.4
Brain and ONSg 2.8 -0.4
Urinary Bladder 2.4 -1.2*
Esophagus 2.3 0.0

Footnotes:

Source: US Mortality Files, National Center for Health Statistics, Centers for Disease Control and Prevention.

a Top 15 cancer sites selected based on 2007-2011 age-adjusted rates for the race/ethnic group.

b Rates are per 100,000 and age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130).

c The APC is the Annual Percent Change over the time interval. Trends are based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130).

d Rates for American Indian/Alaska Native are based on the CHSDA(Contract Health Service Delivery Area) counties.

e Hispanic is not mutually exclusive from whites, blacks, Asian/Pacific Islanders, and American Indians/Alaska Natives.

f The rates for sex-specific cancer sites are calculated using the population for both sexes combined.

g IBD = Intrahepatic Bile Duct. ONS = Other Nervous System.

* The APC is significantly different from zero (p<.05).

- Statistic not shown. Rate based on less than 16 cases for the time interval. Trend based on less than 10 cases for at least one year within the time interval.

Return to top

Page Navigation: << Previous Next >>


The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.